Wanxing Cui
Georgetown University
Dr. Wanxing Cui is the director of the Cell Therapy Manufacturing Facility at Medstar Georgetown University Hospital. Dr. Cui received medical training in Shenyang, China, and practiced general surgery as a resident surgeon for three years. He earned his Ph.D. degree at Kyoto University, Japan, in 2001 with research on bioartificial pancreas development. Since then, Dr. Cui has been working on pancreatic islet transplantation at Emory University, the University of Alabama at Birmingham, and Georgetown University for more than twenty years. His research covers a wide spectrum from basic studies with rodent islets and preclinical studies with non-human primate islets to clinical trials with human islets, using a multidisciplinary translational approach. Dr. Cui has published 58 scientific papers and possesses five islet and bioengineering-related patents currently. Dr. Cui has been a standing International Pancreas and Islet Transplant Association (IPITA) member for more than 20 years. At present, Dr. Cui is an active committee member of the Association for the Advanced of Blood and Biotherapies (AABB) cellular therapies section.
Recapitulation of metabolic defects in a model of propionic acidemia using patient-derived primary hepatocytes.
Molecular genetics and metabolism Mar, 2016 | Pubmed ID: 26740382
A bio-inspired hybrid nanosack for graft vascularization at the omentum.
Acta biomaterialia 09, 2016 | Pubmed ID: 27286678
α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.
Diabetes 04, 2017 | Pubmed ID: 28069642
Carbon Monoxide Inhibits Islet Apoptosis via Induction of Autophagy.
Antioxidants & redox signaling 05, 2018 | Pubmed ID: 28826228
Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function.
Stem cell research & therapy 08, 2017 | Pubmed ID: 28854965
Effect of liver histopathology on islet cell engraftment in the model mimicking autologous islet cell transplantation.
Islets 11, 2017 | Pubmed ID: 28902579
Long-term culture and characterization of patient-derived primary hepatocytes using conditional reprogramming.
Experimental biology and medicine (Maywood, N.J.) 08, 2019 | Pubmed ID: 31184925
Encapsulation of Human Islets Using a Biomimetic Self-Assembled Nanomatrix Gel for Protection against Cellular Inflammatory Responses.
ACS biomaterials science & engineering Sep, 2017 | Pubmed ID: 31289747
Establishment of ornithine transcarbamylase deficiency-derived primary human hepatocyte with hepatic functions.
Experimental cell research 11, 2019 | Pubmed ID: 31513782
Human Amniotic Epithelial Cells and Human Amniotic Membrane as a Vehicle for Islet Cell Transplantation.
Transplantation proceedings Apr, 2020 | Pubmed ID: 32113692
Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons Oct, 2020 | Pubmed ID: 33047509
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved